🔗 Share this article Individuals Stopping Weight-Loss Jabs Regain Weight Far More Rapidly Than Those on Conventional Diets Obesity treatment involves long-term strategies. A recent study indicates that people who stop using popular weight-loss injections like Mounjaro or Wegovy can put back on lost weight far faster than those who stop conventional lifestyle regimens. Research printed in a major health publication shows that while overweight individuals can lose a large proportion of their total mass while undergoing treatment, the weight comes back at an average rate of 0.8 kg per month upon discontinuation. "Individuals buying such treatments need to be informed of the potential of quick weight regain when the medication ends," cautioned researcher Dr. Susan Jebb. This pace of regain suggests a return to original mass in about a year and a half. Comparing Therapies The study, which examined 37 of studies involving thousands of patients, contrasted the outcomes of the injectable medications with older methods. The team note that people who lose weight through diet and exercise usually experience a more gradual weight regain—around 0.1 kg a month—post-intervention. Explaining the Quick Rebound Doctors believe the mechanism of the injections accounts for the accelerated rebound. The injections copy a natural hormone called GLP-1, which controls hunger. "Sustained high doses of the hormone levels several times higher than the body's typical production may cause the system to produce less of its own natural hormone, and could lessen sensitivity to its actions," noted Dr. Adam Collins, a dietetics expert. "Discontinuation of this medication results in hunger is no longer kept in check, making overeating a significant risk." An Ongoing Condition? Health authorities recommend the jabs for people with weight-linked medical conditions, alongside recommended lifestyle changes. Many experts contend that, considering the likelihood of weight regain, the therapy is often ongoing. This perspective is supported by pharmaceutical companies, who say that the results "emphasize the chronic nature of excess weight," comparing it to managing diseases like high blood pressure. User Experiences Users who have come off the medication describe a sudden return of appetite. "I experienced a switch flipping and you're instantly starving," recalled one woman. The struggle is compounded if individuals have not adopted sustainable dietary or behavioural changes during therapy. Growing Interest Figures indicate that a significant number of adults in the UK have tried weight-loss jabs in the past year, with interest being substantial. Adoption is higher among women compared to males. The 40s and 50s demographic shows the greatest level of interest. A large proportion obtain the medications through private prescriptions rather than public health services. In conclusion, experts stress that while these medications are effective agents for shedding pounds, they are not a permanent cure and long-term success relies on combined behavioural support.
Obesity treatment involves long-term strategies. A recent study indicates that people who stop using popular weight-loss injections like Mounjaro or Wegovy can put back on lost weight far faster than those who stop conventional lifestyle regimens. Research printed in a major health publication shows that while overweight individuals can lose a large proportion of their total mass while undergoing treatment, the weight comes back at an average rate of 0.8 kg per month upon discontinuation. "Individuals buying such treatments need to be informed of the potential of quick weight regain when the medication ends," cautioned researcher Dr. Susan Jebb. This pace of regain suggests a return to original mass in about a year and a half. Comparing Therapies The study, which examined 37 of studies involving thousands of patients, contrasted the outcomes of the injectable medications with older methods. The team note that people who lose weight through diet and exercise usually experience a more gradual weight regain—around 0.1 kg a month—post-intervention. Explaining the Quick Rebound Doctors believe the mechanism of the injections accounts for the accelerated rebound. The injections copy a natural hormone called GLP-1, which controls hunger. "Sustained high doses of the hormone levels several times higher than the body's typical production may cause the system to produce less of its own natural hormone, and could lessen sensitivity to its actions," noted Dr. Adam Collins, a dietetics expert. "Discontinuation of this medication results in hunger is no longer kept in check, making overeating a significant risk." An Ongoing Condition? Health authorities recommend the jabs for people with weight-linked medical conditions, alongside recommended lifestyle changes. Many experts contend that, considering the likelihood of weight regain, the therapy is often ongoing. This perspective is supported by pharmaceutical companies, who say that the results "emphasize the chronic nature of excess weight," comparing it to managing diseases like high blood pressure. User Experiences Users who have come off the medication describe a sudden return of appetite. "I experienced a switch flipping and you're instantly starving," recalled one woman. The struggle is compounded if individuals have not adopted sustainable dietary or behavioural changes during therapy. Growing Interest Figures indicate that a significant number of adults in the UK have tried weight-loss jabs in the past year, with interest being substantial. Adoption is higher among women compared to males. The 40s and 50s demographic shows the greatest level of interest. A large proportion obtain the medications through private prescriptions rather than public health services. In conclusion, experts stress that while these medications are effective agents for shedding pounds, they are not a permanent cure and long-term success relies on combined behavioural support.